Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis
Status:
Terminated
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This trial is designed to evaluate olanzapine compared to the metoclopramide in the treatment
of break through emesis after prophylaxis with dexamethasone, 5-HT 3 receptor antagonists and
aprepitant in patients receiving chemotherapy. Efficacy will be assessed using a modified
MASCC questionaire with a visual analog scale.